Anne‐Françoise Schlit

Brivaracetam in Unverricht‐Lundborg disease (<scp>EPM</scp>1): Results from two randomized, double‐blind, placebo‐controlled studies

Reetta Kälviäinen, Pierre Genton, Eva Andermann et al. · Epilepsia · 2015 · 53 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +15

Risk of <scp>QT</scp> prolongation and torsade de pointes associated with exposure to hydroxyzine: re‐evaluation of an established drug

Anne‐Françoise Schlit, Annie Delaunois, Aurore Colomar et al. · Pharmacology Research & Perspectives · 2017 · 38 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17

ACQUIRED ACTIVATED PROTEIN C RESISTANCE IN PREGNANCY

Anne‐Françoise Schlit, Christiane COL-DE BEYS, M Moriau et al. · Thrombosis Research · 1996 · 20 citations

Life Sciences, Immunology, Obstetrics +10

Levetiracetam in a broad population of patients with refractory epilepsy: interim results of the international SKATE trial

Pierre Genton, Bernard Sadzot, Natalio Fejerman et al. · Acta Neurologica Scandinavica · 2006 · 18 citations

Medicine, Pharmacology, Pharmacotherapy +14

Safety of cetirizine in pregnancy

Amanda Golembesky, Maureen Cooney, Rossen Boev et al. · Journal of Obstetrics and Gynaecology · 2018 · 18 citations · Full text

Medicine, Obstetrics, Pharmacotherapy +17